Skip to main content
. 2021 Aug 18;61(10):607–618. doi: 10.2176/nmc.oa.2021-0094

Table 4. Outcomes of the DBS and non-DBS groups.

Factor DBS group (n = 13) Non-DBS group (n = 15) p value
JOA
JOA before surgery (IQR) 8 (4–10) 9 (6.5–12.5) 0.41
JOA after surgery (IQR) 18 (11–23) 20 (10–21) 0.64
JOA at 2 years (IQR) 18 (10.8–23.3) 17.5 (10–22) 0.72
JOA improvement rate after surgery, % (IQR) 46.7 (33.3–76.2) 40 (33.3–63.6) 0.7
 <30 after surgery (%) 1 (7.7) 3 (20.0) 0.47
 30–50 after surgery (%) 7 (53.9) 5 (33.3)
 50≤ after surgery (%) 5 (38.5) 7 (46.7)
JOA improvement rate at 2 years, % (IQR) 39.8 (25.8–81) 51.7 (18.1–61.9) 0.66
 <30 at 2 years (%) 3 (25.0) 4 (28.6) 0.51
 30–50 at 2 years (%) 4 (33.3) 2 (14.3)
 50≤ at 2 years (%) 5 (41.7) 8 (57.1)
NRS
NRS before surgery (IQR) 10 (9–10) 7 (5–8) 0.002
NRS after surgery (IQR) 2 (2–4) 2 (2–3) 0.67
NRS at 2 years (IQR) 2.5 (2.0–4.5) 3 (2–3.8) 0.96
NRS reduction rate after surgery, % (IQR) 77.8 (18.8–84.5) 71.4 (0–77.8) 0.36
 <50 after surgery (%) 4 (30.8) 6 (40.0) 0.88
 50–70 after surgery (%) 1 (7.7) 1 (6.7)
 70≤ after surgery (%) 8 (61.5) 8 (53.3)
NRS reduction rate at 2 years, % (IQR) 75.0 (10–80] 41.5 (0–78.1) 0.38
 <50 at 2 years (%) 5 (41.7) 8 (57.1) 0.19
 50–70 at 2 years (%) 0 (0.0) 2 (14.3)
 70≤ at 2 years (%) 7 (58.3) 4 (28.6)
Hospitalization
Duration of hospitalization, days 26.9 ± 11.5 23.4 ± 11.5 0.43
Duration of hospitalization ≥30 days (%) 5 (38.5) 1 (6.7) 0.069
Complications
All complications (%) 3 (23.1) 7 (46.7) 0.25
Infection (%) 1 (7.7) 2 (13.3) 1
Delirium (%) 2 (15.4) 5 (33.3) 0.4
Fall (%) 0 (0.0) 2 (13.3) 0.48
Other complications (%) 0 (0.0) 4 (26.7) 0.1
Implant failure (%) 1 (7.7) 1 (6.7) 1
Reoperation (%) 2 (15.4) 2 (13.3) 1

DBS: deep brain stimulation, IQR: interquartile range, JOA: The Japanese Orthopedic Association, NRS: numerical rating scale, PD: Parkinson’s disease.